Legend Biotech Corp Stock Technical Analysis
| LEGN Stock | USD 18.54 0.63 3.52% |
As of the 11th of February 2026, Legend Biotech secures the Risk Adjusted Performance of (0.19), mean deviation of 2.41, and Standard Deviation of 3.29. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Legend Biotech Corp, as well as the relationship between them.
Legend Biotech Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Legend, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to LegendLegend Biotech's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Legend Biotech Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 64.07 | Strong Buy | 22 | Odds |
Most Legend analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Legend stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Legend Biotech Corp, talking to its executives and customers, or listening to Legend conference calls.
Will Biotechnology sector continue expanding? Could Legend diversify its offerings? Factors like these will boost the valuation of Legend Biotech. Expected growth trajectory for Legend significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Legend Biotech data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (1.28) | Revenue Per Share | Quarterly Revenue Growth 0.7 | Return On Assets | Return On Equity |
Investors evaluate Legend Biotech Corp using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Legend Biotech's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Legend Biotech's market price to deviate significantly from intrinsic value.
Understanding that Legend Biotech's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Legend Biotech represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Legend Biotech's market price signifies the transaction level at which participants voluntarily complete trades.
Legend Biotech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Legend Biotech's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Legend Biotech.
| 11/13/2025 |
| 02/11/2026 |
If you would invest 0.00 in Legend Biotech on November 13, 2025 and sell it all today you would earn a total of 0.00 from holding Legend Biotech Corp or generate 0.0% return on investment in Legend Biotech over 90 days. Legend Biotech is related to or competes with Disc Medicine, Zai Lab, Ascentage Pharma, Tarsus Pharmaceuticals, Adaptive Biotechnologies, Scholar Rock, and Celcuity LLC. Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discove... More
Legend Biotech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Legend Biotech's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Legend Biotech Corp upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.28) | |||
| Maximum Drawdown | 19.65 | |||
| Value At Risk | (6.84) | |||
| Potential Upside | 3.97 |
Legend Biotech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Legend Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Legend Biotech's standard deviation. In reality, there are many statistical measures that can use Legend Biotech historical prices to predict the future Legend Biotech's volatility.| Risk Adjusted Performance | (0.19) | |||
| Jensen Alpha | (0.84) | |||
| Total Risk Alpha | (1.17) | |||
| Treynor Ratio | (17.01) |
Legend Biotech February 11, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.19) | |||
| Market Risk Adjusted Performance | (17.00) | |||
| Mean Deviation | 2.41 | |||
| Coefficient Of Variation | (400.33) | |||
| Standard Deviation | 3.29 | |||
| Variance | 10.82 | |||
| Information Ratio | (0.28) | |||
| Jensen Alpha | (0.84) | |||
| Total Risk Alpha | (1.17) | |||
| Treynor Ratio | (17.01) | |||
| Maximum Drawdown | 19.65 | |||
| Value At Risk | (6.84) | |||
| Potential Upside | 3.97 | |||
| Skewness | (0.32) | |||
| Kurtosis | 1.52 |
Legend Biotech Corp Backtested Returns
Legend Biotech Corp has Sharpe Ratio of -0.23, which conveys that the firm had a -0.23 % return per unit of risk over the last 3 months. Legend Biotech exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Legend Biotech's Standard Deviation of 3.29, risk adjusted performance of (0.19), and Mean Deviation of 2.41 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 0.0489, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Legend Biotech's returns are expected to increase less than the market. However, during the bear market, the loss of holding Legend Biotech is expected to be smaller as well. At this point, Legend Biotech Corp has a negative expected return of -0.78%. Please make sure to verify Legend Biotech's skewness, and the relationship between the total risk alpha and rate of daily change , to decide if Legend Biotech Corp performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.87 |
Very good predictability
Legend Biotech Corp has very good predictability. Overlapping area represents the amount of predictability between Legend Biotech time series from 13th of November 2025 to 28th of December 2025 and 28th of December 2025 to 11th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Legend Biotech Corp price movement. The serial correlation of 0.87 indicates that approximately 87.0% of current Legend Biotech price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.87 | |
| Spearman Rank Test | 0.75 | |
| Residual Average | 0.0 | |
| Price Variance | 5.8 |
Legend Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Legend Biotech Corp Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Normalized Average True Range is used to analyze tradable apportunities for Legend Biotech Corp across different markets.
About Legend Biotech Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Legend Biotech Corp on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Legend Biotech Corp based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Legend Biotech Corp price pattern first instead of the macroeconomic environment surrounding Legend Biotech Corp. By analyzing Legend Biotech's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Legend Biotech's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Legend Biotech specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 | 2025 | 2026 (projected) | Interest Debt Per Share | 3.98 | 4.07 | 3.66 | 3.85 | Revenue Per Share | 3.24 | 6.86 | 6.17 | 6.48 |
Legend Biotech February 11, 2026 Technical Indicators
Most technical analysis of Legend help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Legend from various momentum indicators to cycle indicators. When you analyze Legend charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.19) | |||
| Market Risk Adjusted Performance | (17.00) | |||
| Mean Deviation | 2.41 | |||
| Coefficient Of Variation | (400.33) | |||
| Standard Deviation | 3.29 | |||
| Variance | 10.82 | |||
| Information Ratio | (0.28) | |||
| Jensen Alpha | (0.84) | |||
| Total Risk Alpha | (1.17) | |||
| Treynor Ratio | (17.01) | |||
| Maximum Drawdown | 19.65 | |||
| Value At Risk | (6.84) | |||
| Potential Upside | 3.97 | |||
| Skewness | (0.32) | |||
| Kurtosis | 1.52 |
Legend Biotech February 11, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Legend stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 157,309 | ||
| Daily Balance Of Power | 0.54 | ||
| Rate Of Daily Change | 1.04 | ||
| Day Median Price | 18.09 | ||
| Day Typical Price | 18.24 | ||
| Price Action Indicator | 0.77 |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Legend Biotech Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Will Biotechnology sector continue expanding? Could Legend diversify its offerings? Factors like these will boost the valuation of Legend Biotech. Expected growth trajectory for Legend significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Legend Biotech data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (1.28) | Revenue Per Share | Quarterly Revenue Growth 0.7 | Return On Assets | Return On Equity |
Investors evaluate Legend Biotech Corp using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Legend Biotech's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Legend Biotech's market price to deviate significantly from intrinsic value.
Understanding that Legend Biotech's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Legend Biotech represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Legend Biotech's market price signifies the transaction level at which participants voluntarily complete trades.